TW211012B - - Google Patents
Download PDFInfo
- Publication number
- TW211012B TW211012B TW080105785A TW80105785A TW211012B TW 211012 B TW211012 B TW 211012B TW 080105785 A TW080105785 A TW 080105785A TW 80105785 A TW80105785 A TW 80105785A TW 211012 B TW211012 B TW 211012B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- item
- patent application
- ministry
- cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52762590A | 1990-05-23 | 1990-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW211012B true TW211012B (enExample) | 1993-08-11 |
Family
ID=24102273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW080105785A TW211012B (enExample) | 1990-05-23 | 1991-07-25 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0458618A1 (enExample) |
| JP (1) | JPH04226986A (enExample) |
| KR (1) | KR910020011A (enExample) |
| CN (1) | CN1031642C (enExample) |
| AU (1) | AU636034B2 (enExample) |
| CA (1) | CA2042944A1 (enExample) |
| FI (1) | FI912486L (enExample) |
| HU (1) | HUT57768A (enExample) |
| IE (1) | IE911751A1 (enExample) |
| IL (1) | IL98224A (enExample) |
| MY (1) | MY106167A (enExample) |
| NO (1) | NO179909C (enExample) |
| NZ (1) | NZ238122A (enExample) |
| PT (1) | PT97741B (enExample) |
| TN (1) | TNSN91037A1 (enExample) |
| TW (1) | TW211012B (enExample) |
| ZA (1) | ZA913880B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU648070B2 (en) * | 1990-04-23 | 1994-04-14 | Ortho Pharmaceutical Corporation | Process for preparing optically active isomers of 6-substituted purinyl piperazine derivatives |
| JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| WO1999002162A1 (en) * | 1997-07-12 | 1999-01-21 | Cancer Research Campaign Technology Limited | Cyclin dependent kinase inhibiting purine derivatives |
| US20080039321A1 (en) * | 2004-05-12 | 2008-02-14 | Bastiaans Henricus M | Plant Growth Regulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2334009A1 (de) * | 1973-07-04 | 1975-01-23 | Boehringer Mannheim Gmbh | Purin-derivate sowie verfahren zu ihrer herstellung |
| DE3703633A1 (de) * | 1986-02-14 | 1987-08-20 | Sandoz Ag | Purin-derivate, ihre herstellung und sie enthaltende arzneimittel |
| US4876257A (en) * | 1988-03-03 | 1989-10-24 | Ortho Pharmaceutical Corporation | 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents |
-
1991
- 1991-05-10 NZ NZ238122A patent/NZ238122A/en unknown
- 1991-05-21 CA CA002042944A patent/CA2042944A1/en not_active Abandoned
- 1991-05-21 MY MYPI91000860A patent/MY106167A/en unknown
- 1991-05-21 AU AU77233/91A patent/AU636034B2/en not_active Ceased
- 1991-05-22 FI FI912486A patent/FI912486L/fi not_active Application Discontinuation
- 1991-05-22 IL IL9822491A patent/IL98224A/en not_active IP Right Cessation
- 1991-05-22 EP EP91304632A patent/EP0458618A1/en not_active Withdrawn
- 1991-05-22 KR KR1019910008205A patent/KR910020011A/ko not_active Ceased
- 1991-05-22 HU HU911727A patent/HUT57768A/hu unknown
- 1991-05-22 JP JP3145165A patent/JPH04226986A/ja active Pending
- 1991-05-22 ZA ZA913880A patent/ZA913880B/xx unknown
- 1991-05-22 NO NO911973A patent/NO179909C/no unknown
- 1991-05-22 PT PT97741A patent/PT97741B/pt not_active IP Right Cessation
- 1991-05-22 IE IE175191A patent/IE911751A1/en unknown
- 1991-05-23 TN TNTNSN91037A patent/TNSN91037A1/fr unknown
- 1991-05-23 CN CN91103957A patent/CN1031642C/zh not_active Expired - Fee Related
- 1991-07-25 TW TW080105785A patent/TW211012B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2042944A1 (en) | 1991-11-24 |
| MY106167A (en) | 1995-03-31 |
| NZ238122A (en) | 1994-01-26 |
| PT97741A (pt) | 1992-02-28 |
| FI912486A7 (fi) | 1991-11-24 |
| NO911973D0 (no) | 1991-05-22 |
| KR910020011A (ko) | 1991-12-19 |
| JPH04226986A (ja) | 1992-08-17 |
| PT97741B (pt) | 1998-10-30 |
| NO179909B (no) | 1996-09-30 |
| ZA913880B (en) | 1993-01-27 |
| AU636034B2 (en) | 1993-04-08 |
| TNSN91037A1 (fr) | 1992-10-25 |
| NO911973L (no) | 1991-11-25 |
| IL98224A (en) | 1995-07-31 |
| HUT57768A (en) | 1991-12-30 |
| IE911751A1 (en) | 1991-12-04 |
| FI912486A0 (fi) | 1991-05-22 |
| EP0458618A1 (en) | 1991-11-27 |
| IL98224A0 (en) | 1992-06-21 |
| FI912486L (fi) | 1991-11-24 |
| CN1031642C (zh) | 1996-04-24 |
| NO179909C (no) | 1997-01-08 |
| AU7723391A (en) | 1991-11-28 |
| CN1057463A (zh) | 1992-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5097701B2 (ja) | Ｒｈｏ−キナーゼの阻害剤としてのイソキノリン誘導体 | |
| US8680139B2 (en) | Anti-neoplastic compounds, compositions and methods | |
| CN102203059B (zh) | 取代的氨基茚满及其类似物以及其医药用途 | |
| AU2017367086A1 (en) | Compounds containing a sulfonic group as KAT inhibitors | |
| CA2935071A1 (en) | Piperidine-dione derivatives | |
| BR112015020152B1 (pt) | Sais de adição cristalino farmaceuticamente aceitável de 2-amino-1-hidroxietil-8hidroxiquinolin-2(1h)-ona, composição farmacêutica e uso | |
| US7056923B2 (en) | Platelet adenosine diphosphate receptor antagonists | |
| JP2025031757A (ja) | Ｐａｒｐ１阻害薬及びその使用 | |
| EP3398598A1 (en) | Sulfonamide derivative and preparation method and use thereof | |
| TW200904409A (en) | Azetidines | |
| TWI254706B (en) | Cyclic amine compounds and pharmaceutical composition containing the same | |
| PT77855B (en) | Pyridine derivatives | |
| JP2021059578A (ja) | オキシンドール化合物およびその医薬組成物 | |
| TW211012B (enExample) | ||
| CN105175360B (zh) | 醚类芳基哌嗪衍生物及其盐、制备方法和用途 | |
| KR101532101B1 (ko) | 설포닐-퀴놀린 유도체 | |
| JPS5982384A (ja) | 硫黄含有インド−ル誘導体 | |
| EA010392B1 (ru) | Производные имидазолов, способ их получения и их применение в качестве лекарственного средства | |
| TW502032B (en) | Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists | |
| TW421646B (en) | Benzopyran derivatives having K<+>-channel opening activity | |
| JPH047745B2 (enExample) | ||
| JPS60214778A (ja) | Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途 | |
| JP2025504963A (ja) | Ａｍｐｋアゴニスト及びその使用方法 | |
| TW200418813A (en) | Novel compounds | |
| CA3102777A1 (en) | Prc1 inhibitors and methods of treatment therewith |